APONTIS PHARMA AG had a revenue of 22.73M in the quarter ending Jun 30, 2024, with 26.92%. This bring the company's revenue in the last twelve months to 40.63M, Decreased 9.92%. In the fiscal year ending Dec 31, 2024, APONTIS PHARMA AG had annual revenue of 48.47M with 31.12% growth.